Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment.

Saved in:
Bibliographic Details
Title: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment.
Authors: Jennings VA; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Rumbold-Hall R; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Migneco G; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Barr T; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Reilly K; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Ingram N; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., St Hilare I; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Heaton S; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Alzamel N; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Jackson D; Leeds Cancer Centre, St James's Hospital, Leeds, United Kingdom., Ralph C; Leeds Cancer Centre, St James's Hospital, Leeds, United Kingdom., Banerjee S; The Royal Marsden Hospital, Fulham Road, London, United Kingdom., McNeish I; Department of Cancer and Surgery, Imperial College London, London, United Kingdom., Bell JC; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Melcher AA; The Institute of Cancer Research, Divisions of Radiotherapy and Imaging and Breast Cancer Research, Chester Beatty Laboratories, London, United Kingdom., Ilkow C; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Cook GP; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom., Errington-Mais F; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.
Source: Frontiers in immunology [Front Immunol] 2024 Dec 23; Vol. 15, pp. 1500570. Date of Electronic Publication: 2024 Dec 23 (Print Publication: 2024).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39763667
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jennings+VA%22">Jennings VA</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rumbold-Hall+R%22">Rumbold-Hall R</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Migneco+G%22">Migneco G</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Barr+T%22">Barr T</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Reilly+K%22">Reilly K</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ingram+N%22">Ingram N</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22St+Hilare+I%22">St Hilare I</searchLink>; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Heaton+S%22">Heaton S</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Alzamel+N%22">Alzamel N</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jackson+D%22">Jackson D</searchLink>; Leeds Cancer Centre, St James's Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ralph+C%22">Ralph C</searchLink>; Leeds Cancer Centre, St James's Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Banerjee+S%22">Banerjee S</searchLink>; The Royal Marsden Hospital, Fulham Road, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McNeish+I%22">McNeish I</searchLink>; Department of Cancer and Surgery, Imperial College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bell+JC%22">Bell JC</searchLink>; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Melcher+AA%22">Melcher AA</searchLink>; The Institute of Cancer Research, Divisions of Radiotherapy and Imaging and Breast Cancer Research, Chester Beatty Laboratories, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ilkow+C%22">Ilkow C</searchLink>; Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Cook+GP%22">Cook GP</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Errington-Mais+F%22">Errington-Mais F</searchLink>; Leeds Institute of Medical Research, School of Medicine, University of Leeds, St. James University Hospital, Leeds, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Dec 23; Vol. 15, pp. 1500570. <i>Date of Electronic Publication: </i>2024 Dec 23 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39763667
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2024.1500570
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1500570
    Titles:
      – TitleFull: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jennings VA
      – PersonEntity:
          Name:
            NameFull: Rumbold-Hall R
      – PersonEntity:
          Name:
            NameFull: Migneco G
      – PersonEntity:
          Name:
            NameFull: Barr T
      – PersonEntity:
          Name:
            NameFull: Reilly K
      – PersonEntity:
          Name:
            NameFull: Ingram N
      – PersonEntity:
          Name:
            NameFull: St Hilare I
      – PersonEntity:
          Name:
            NameFull: Heaton S
      – PersonEntity:
          Name:
            NameFull: Alzamel N
      – PersonEntity:
          Name:
            NameFull: Jackson D
      – PersonEntity:
          Name:
            NameFull: Ralph C
      – PersonEntity:
          Name:
            NameFull: Banerjee S
      – PersonEntity:
          Name:
            NameFull: McNeish I
      – PersonEntity:
          Name:
            NameFull: Bell JC
      – PersonEntity:
          Name:
            NameFull: Melcher AA
      – PersonEntity:
          Name:
            NameFull: Ilkow C
      – PersonEntity:
          Name:
            NameFull: Cook GP
      – PersonEntity:
          Name:
            NameFull: Errington-Mais F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 12
              Text: 2024 Dec 23
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1